These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 28618926)
1. Diagnostic relevance of a novel multiplex immunoassay panel in breast cancer. Hermann N; Dressen K; Schroeder L; Debald M; Schildberg FA; Walgenbach-Bruenagel G; Hettwer K; Uhlig S; Kuhn W; Hartmann G; Holdenrieder S Tumour Biol; 2017 Jun; 39(6):1010428317711381. PubMed ID: 28618926 [TBL] [Abstract][Full Text] [Related]
2. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers. Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of a Novel Multiplex Immunoassay in Colorectal Cancer. Dressen K; Hermann N; Manekeller S; Walgenbach-Bruenagel G; Schildberg FA; Hettwer K; Uhlig S; Kalff JC; Hartmann G; Holdenrieder S Anticancer Res; 2017 May; 37(5):2477-2486. PubMed ID: 28476816 [TBL] [Abstract][Full Text] [Related]
4. Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-based Assays. Dolscheid-Pommerich RC; Manekeller S; Walgenbach-Brünagel G; Kalff JC; Hartmann G; Wagner BS; Holdenrieder S Anticancer Res; 2017 Jan; 37(1):353-359. PubMed ID: 28011514 [TBL] [Abstract][Full Text] [Related]
5. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA). Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221 [TBL] [Abstract][Full Text] [Related]
6. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer. Findeisen R; Albrecht S; Richter B; Deutschmann K; Zimmermann T; Distler W Luminescence; 2000; 15(5):283-9. PubMed ID: 11038485 [TBL] [Abstract][Full Text] [Related]
7. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor. El-Attar NI; Gaefar HA Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers in the treatment of cancer: opportunities and pitfalls. Melichar B Clin Chem Lab Med; 2013 Jul; 51(7):1329-33. PubMed ID: 23729626 [No Abstract] [Full Text] [Related]
9. A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum. Opstal-van Winden AW; Rodenburg W; Pennings JL; van Oostrom CT; Beijnen JH; Peeters PH; van Gils CH; de Vries A Int J Mol Sci; 2012 Oct; 13(10):13587-604. PubMed ID: 23202969 [TBL] [Abstract][Full Text] [Related]
10. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3. Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906 [TBL] [Abstract][Full Text] [Related]
11. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory. Hui L; Rixv L; Xiuying Z Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289 [TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies. Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985 [TBL] [Abstract][Full Text] [Related]
13. Tumour markers with clinically controlled cut-offs for suspected cancer. Bosch X; Molina R; Marrades R; Augé JM; Pellicé M; López-Soto A Eur J Clin Invest; 2021 Jul; 51(7):e13523. PubMed ID: 33594702 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules. Bekci TT; Senol T; Maden E J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238 [TBL] [Abstract][Full Text] [Related]
15. Effect of obesity-related plasma hemodilution on serum tumor marker concentration in women. Park M; Chang IH; Kang H; Han SS J Obstet Gynaecol Res; 2015 May; 41(5):784-9. PubMed ID: 25421332 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. Kim JH; Jun KH; Jung H; Park IS; Chin HM Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088 [TBL] [Abstract][Full Text] [Related]
17. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1. Attallah AM; El-Far M; Ibrahim AR; El-Desouky MA; Omran MM; Elbendary MS; Attallah KA; Qura ER; Abdallah SO Br J Biomed Sci; 2018 Jul; 75(3):122-127. PubMed ID: 29734875 [TBL] [Abstract][Full Text] [Related]
18. [1959-1999: from serum markers to 18-FDG in oncology. The experience of the René-Huguenin Center]. Pecking AP; Mechelany-Corone C; Pichon MF Pathol Biol (Paris); 2000 Nov; 48(9):819-24. PubMed ID: 11141917 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay. Horala A; Swiatly A; Matysiak J; Banach P; Nowak-Markwitz E; Kokot ZJ Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075407 [TBL] [Abstract][Full Text] [Related]
20. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer. Jiang XT; Tao HQ; Zou SC Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]